Form EFFECT CNS Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 26, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The IAIABC Swears in Board of Directors for 2026-2027 Term
- AM Best Revises Outlooks to Negative for Western Surety Company
- TechMediaBreaks – AI Maverick Intel Inc. (OTCID: AIMV) Signs Definitive Agreement to Acquire Heal Access Canada
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share